We identified a scoring system based on CBFβ::MYH11, RUNX1::RUNX1T1, KMT2A::ELL, and KMT2A::MLLT10 that was significantly associated with the OS of patients with non-APL pediatric AML. This evidence concerns the gene MLLT10 and acute myeloid leukemia.